OTIS vs VRTX · P/E 19, rev $7.42B vs P/E 30, rev $3.33B
Otis Worldwide Corp (OTIS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Otis Worldwide Corp (OTIS) is a specialty industrial machinery company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported OTIS revenue for 2026-06-30 was $7.42B. Net income was $768.0M. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
OTIS currently screens at market cap $27.90B and trailing P/E 19.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the OTIS and VRTX stock pages for the full models.
Not investment advice.